Olanzapine-induced hyperglycaemic coma and neuroleptic malignant syndrome: case report and review of literature.


Although the relationship between antipsychotic medication, particularly second-generation antipsychotics (SGAs), and metabolic disturbance is increasingly accepted, there is an important, but little recognised, potential interaction between this and the other important serious adverse effect of neuroleptic malignant syndrome (NMS). We report a case of a 35… (More)
DOI: 10.1177/0269881108096901


  • Presentations referencing similar topics